These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29886723)

  • 1. Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.
    Duering M; Konieczny MJ; Tiedt S; Baykara E; Tuladhar AM; Leijsen EV; Lyrer P; Engelter ST; Gesierich B; Achmüller M; Barro C; Adam R; Ewers M; Dichgans M; Kuhle J; de Leeuw FE; Peters N
    J Stroke; 2018 May; 20(2):228-238. PubMed ID: 29886723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Neurofilament Light Chain Is Associated with Incident Lacunes in Progressive Cerebral Small Vessel Disease.
    Peters N; van Leijsen E; Tuladhar AM; Barro C; Konieczny MJ; Ewers M; Lyrer P; Engelter ST; Kuhle J; Duering M; de Leeuw FE
    J Stroke; 2020 Sep; 22(3):369-376. PubMed ID: 33053952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel Disease.
    Konieczny MJ; Dewenter A; Ter Telgte A; Gesierich B; Wiegertjes K; Finsterwalder S; Kopczak A; Hübner M; Malik R; Tuladhar AM; Marques JP; Norris DG; Koch A; Dietrich O; Ewers M; Schmidt R; de Leeuw FE; Duering M
    Neurology; 2021 Feb; 96(5):e698-e708. PubMed ID: 33199431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Neurofilament light correlates with CADASIL disease severity and survival.
    Gravesteijn G; Rutten JW; Verberk IMW; Böhringer S; Liem MK; van der Grond J; Aartsma-Rus A; Teunissen CE; Lesnik Oberstein SAJ
    Ann Clin Transl Neurol; 2019 Jan; 6(1):46-56. PubMed ID: 30656183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL.
    Chen CH; Cheng YW; Chen YF; Tang SC; Jeng JS
    J Neuroinflammation; 2020 Apr; 17(1):124. PubMed ID: 32321529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The INECO Frontal Screening for the Evaluation of Executive Dysfunction in Cerebral Small Vessel Disease: Evidence from Quantitative MRI in a CADASIL Cohort from Colombia.
    Schoemaker D; Zuluaga Y; Viswanathan A; Shrimer D; Torrico-Teave H; Velilla L; Ospina C; Ospina GG; Lopera F; Arboleda-Velasquez JF; Quiroz YT
    J Int Neuropsychol Soc; 2020 Nov; 26(10):1006-1018. PubMed ID: 32487276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the "ZOOM@SVDs" study.
    van den Brink H; Kopczak A; Arts T; Onkenhout L; Siero JCW; Zwanenburg JJM; Duering M; Blair GW; Doubal FN; Stringer MS; Thrippleton MJ; Kuijf HJ; de Luca A; Hendrikse J; Wardlaw JM; Dichgans M; Biessels GJ;
    Cereb Circ Cogn Behav; 2021; 2():100013. PubMed ID: 36324717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Fiber Pathology in CADASIL: Clinical Correlation With Cognitive Impairment.
    Cheng YW; Chao CC; Chen CH; Yeh TY; Jeng JS; Tang SC; Hsieh ST
    Neurology; 2022 Aug; 99(6):e583-e593. PubMed ID: 35584924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease.
    Rudilosso S; Chui E; Stringer MS; Thrippleton M; Chappell F; Blair GW; Garcia DJ; Doubal F; Hamilton I; Kopczak A; Ingrisch M; Kerkhofs D; Backes WH; Staals J; van Oostenbrugge R; Duering M; Dichgans M; Wardlaw JM;
    Neurology; 2022 Aug; 99(5):e440-e452. PubMed ID: 35606147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging neurovascular, endothelial and structural integrity in preparation to treat small vessel diseases. The INVESTIGATE-SVDs study protocol. Part of the SVDs@Target project.
    Blair GW; Stringer MS; Thrippleton MJ; Chappell FM; Shuler K; Hamilton I; Garcia DJ; Doubal FN; Kopczak A; Duering M; Ingrisch M; Kerkhofs D; Staals J; van den Brink H; Arts T; Backes WH; van Oostenbrugge R; Biessels GJ; Dichgans M; Wardlaw JM
    Cereb Circ Cogn Behav; 2021; 2():100020. PubMed ID: 36324725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cognitive profiles of CADASIL and sporadic small vessel disease.
    Charlton RA; Morris RG; Nitkunan A; Markus HS
    Neurology; 2006 May; 66(10):1523-6. PubMed ID: 16717212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIHSS scores in ischemic small vessel disease: a study in CADASIL.
    Yao M; Hervé D; Allili N; Jouvent E; Duering M; Dichgans M; Chabriat H
    Cerebrovasc Dis; 2012; 34(5-6):419-23. PubMed ID: 23221354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study.
    van Gennip ACE; Satizabal CL; Tracy RP; Sigurdsson S; Gudnason V; Launer LJ; van Sloten TT
    Geroscience; 2024 Feb; 46(1):505-516. PubMed ID: 37530894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring causal pathways linking cerebral small vessel diseases burden to poststroke depressive symptoms with structural equation model analysis.
    Liang Y; Chen YK; Liu YL; Mok VCT; Ungvari GS; Chu WCW; Tang WK; Kim JS; Kim JM
    J Affect Disord; 2019 Jun; 253():218-223. PubMed ID: 31054447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
    Baykara E; Gesierich B; Adam R; Tuladhar AM; Biesbroek JM; Koek HL; Ropele S; Jouvent E; ; Chabriat H; Ertl-Wagner B; Ewers M; Schmidt R; de Leeuw FE; Biessels GJ; Dichgans M; Duering M
    Ann Neurol; 2016 Oct; 80(4):581-92. PubMed ID: 27518166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCD-Profiling Using AVERAGE. A New Technique to Evaluate Transcranial Doppler Ultrasound Flow Spectra of Subjects with Cerebral Small Vessel Disease.
    Fisse AL; Pueschel J; Deppe M; Ringelstein EB; Ritter MA
    Cerebrovasc Dis; 2016; 41(1-2):50-9. PubMed ID: 26599357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial activation and blood-brain barrier permeability in cerebral small vessel disease.
    Walsh J; Tozer DJ; Sari H; Hong YT; Drazyk A; Williams G; Shah NJ; O'Brien JT; Aigbirhio FI; Rosenberg G; Fryer TD; Markus HS
    Brain; 2021 Jun; 144(5):1361-1371. PubMed ID: 34000009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL.
    Viswanathan A; Gschwendtner A; Guichard JP; Buffon F; Cumurciuc R; O'Sullivan M; Holtmannspötter M; Pachai C; Bousser MG; Dichgans M; Chabriat H
    Neurology; 2007 Jul; 69(2):172-9. PubMed ID: 17620550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free water determines diffusion alterations and clinical status in cerebral small vessel disease.
    Duering M; Finsterwalder S; Baykara E; Tuladhar AM; Gesierich B; Konieczny MJ; Malik R; Franzmeier N; Ewers M; Jouvent E; Biessels GJ; Schmidt R; de Leeuw FE; Pasternak O; Dichgans M
    Alzheimers Dement; 2018 Jun; 14(6):764-774. PubMed ID: 29406155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into mechanisms of small vessel disease stroke from genetics.
    Tan R; Traylor M; Rutten-Jacobs L; Markus H
    Clin Sci (Lond); 2017 Apr; 131(7):515-531. PubMed ID: 28302914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.